Editorial: Genetic Testing for BRCA Mutations Today and Tomorrow—About the ABOUT Study

JAMA Network Article

REFERENCES

ARTICLE INFORMATION | REFERENCES

1

Armstrong  J, Toscano  M, Kotchko  N,  et al.  Utilization and outcomes of BRCA genetic testing and counseling in a national commercially insured population: the ABOUT study [published online October 1, 2015]. JAMA Oncol. doi:10.1001/jamaoncol.2015.3048.

2

Metcalfe  K, Lynch  HT, Foulkes  WD,  et al.  Effect of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. JAMA Oncol. 2015;1(3):306-313.
PubMed   |  Link to Article

3

Metcalfe  K, Gershman  S, Ghadirian  P,  et al.  Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ. 2014;348:g226.
PubMed   |  Link to Article

4

Finch  AP, Lubinski  J, Møller  P,  et al.  Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol. 2014;32(15):1547-1553.
PubMed   |  Link to Article

5

Metcalfe  KA, Mian  N, Enmore  M,  et al.  Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening. Breast Cancer Res Treat. 2012;133(2):735-740.
PubMed   |  Link to Article

6

Gronwald  J, Huzarski  T, Byrski  T,  et al.  Direct-to-patient BRCA1 testing: the Twoj Styl experience. Breast Cancer Res Treat. 2006;100(3):239-245.
PubMed   |  Link to Article

7

Metcalfe  KA, Poll  A, Royer  R,  et al.  A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing. Br J Cancer. 2013;109(3):777-779.
PubMed   |  Link to Article